Asia-Pacific Artificial Intelligence (Ai) In Healthcare Market 2024-2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	131 Pages	Triton Market Research	March, 2024	TRTN18642489

Best Price Guarantee
Price	from $1,500
Length	131 Pages
Publisher	Triton Market Research
Published Date	March, 2024
SKU	TRTN18642489

Asia-Pacific Artificial Intelligence (Ai) In Healthcare Market 2024-2032

Market Outlook

Based on Triton’s report, the Asia-Pacific artificial intelligence (AI) in healthcare market is set to attain revenue growth at a CAGR of 38.39% during the forecast period 2024-2032. ASEAN countries, India, China, Australia & New Zealand, South Korea, Japan, and the Rest of Asia-Pacific are assessed in the region’s market.

The Indian healthcare AI sector is rapidly evolving, propelled by substantial investments in healthcare technology. Recent data indicates a projected acceleration in the global healthcare IT industry growth in the coming years.

Notably, startups like Sigtuple, Aindra, Niramai, Advenio Technosys, Touchkin, and Predible Health are making substantial advancements in India. They are pioneering innovative technologies and products with a focus on precision medicine and genome testing. Furthermore, emerging startups like Sarvam AI are delving into generative AI, including voice-based interfaces for extensive language models.

On the other hand, South Korea has been witnessing a gradual rise in the adoption of Electronic Medical Records (EMR). There is an expectation that all medical and health records, along with data from personal medical devices, will be consolidated into a patient’s medical app. This move ensures patients have a unified record and complete control over their health data. Despite this progress, the adoption rate of fully comprehensive EMR stands at approximately 11.6%. This figure highlights the necessity for further digitization efforts and advanced research in healthcare AI.

Competitive Outlook

The notable enterprises in the AI in healthcare market include Intel Corporation, Oncora Medical, Stryker Corporation, and Microsoft Corporation.

1. Asia-pacific Artificial Intelligence (Ai) In Healthcare Market - Summary
2. Industry Outlook: 2.1. Porter’s Five Forces Analysis; 2.1.1. Buyers Power; 2.1.2. Suppliers Power; 2.1.3. Substitution; 2.1.4. New Entrants; 2.1.5. Industry Rivalry; 2.2. Market Maturity Analysis; 2.3. Value Chain Analysis; 2.3.1. Data Warehouse; 2.3.2. Artificial Intelligence (Ai) Analysis; 2.3.3. Software Development; 2.4. Key Buying Criteria; 2.4.1. Application; 2.4.2. Technology; 2.4.3. Integration With Existing Infrastructure; 2.5. Regulatory Framework; 2.6. Key Market Strategies; 2.6.1. Acquisitions; 2.6.2. Product Launches; 2.6.3. Collaborations; 2.7. Market Drivers; 2.7.1. Adoption Of Ai Being Supported By Large Volumes Of Healthcare Data; 2.7.2. Personalized Medicine In Tests For Clinical Decision-making; 2.7.3. Growing Proactive Government Support And Investments In Ai R&D; 2.7.4. Increasing Start-ups In Ai And Machine Learning; 2.8. Market Challenges; 2.8.1. Cost Constraints And A Low Return On Investment (Roi); 2.8.2. Challenges In Sustaining Data Security; 2.8.3. Slow Adoption Of Ai-based Technologies; 2.9. Market Opportunities; 2.9.1. Expanding Applications Of Ai In The Healthcare Industry; 2.9.2. Rising Demand For Ai In Drug Discovery; 2.9.3. Strong Focus On The Development Of Precision Medicine And Personalized Drugs; 2.9.4. Ai Used To Establish A Real-time Monitoring System; 2.10. Analyst Perspective
3. Asia-pacific Artificial Intelligence (Ai) In Healthcare Market - By Solution: 3.1. Software; 3.2. Services; 3.3. Hardware
4. Asia-pacific Artificial Intelligence (Ai) In Healthcare Market - By Technology: 4.1. Natural Language Processing; 4.2. Querying Method; 4.3. Context Aware Processing; 4.4. Deep Learning
5. Asia-pacific Artificial Intelligence (Ai) In Healthcare Market - By Type: 5.1. Robot-assisted Surgery; 5.2. Virtual Nursing Assistant; 5.3. Administrative Workflow Assistance; 5.4. Fraud Detection; 5.5. Dosage Error Reduction; 5.6. Clinical Trial Participant Identifier; 5.7. Preliminary Diagnosis; 5.8. Other Types
6. Asia-pacific Artificial Intelligence (Ai) In Healthcare Market - By Industry Vertical: 6.1. Healthcare Providers; 6.2. Pharmaceutical And Biotechnology Companies; 6.3. Payers; 6.4. Acos And Mcos; 6.5. Patients
7. Asia-pacific Artificial Intelligence (Ai) In Healthcare Market – By Country Outlook: 7.1. China; 7.1.1. China Artificial Intelligence (Ai) In Healthcare Market Forecast & Prospects; 7.2. Japan; 7.2.1. Japan Artificial Intelligence (Ai) In Healthcare Market Forecast & Prospects; 7.3. India; 7.3.1. India Artificial Intelligence (Ai) In Healthcare Market Forecast & Prospects; 7.4. South Korea; 7.4.1. South Korea Artificial Intelligence (Ai) In Healthcare Market Forecast & Prospects; 7.5. Australia & New Zealand; 7.5.1. Australia & New Zealand Artificial Intelligence (Ai) In Healthcare Market Forecast & Prospects; 7.6. Asean Countries; 7.6.1. Asean Countries Artificial Intelligence (Ai) In Healthcare Market Forecast & Prospects; 7.7. Rest Of Asia-pacific; 7.7.1. Rest Of Asia-pacific Artificial Intelligence (Ai) In Healthcare Market Forecast & Prospects
8. Competitive Landscape: 8.1. Ge Healthcare; 8.1.1. Overview; 8.1.2. Product List; 8.1.3. Key Strengths; 8.1.4. Key Challenges; 8.2. General Vision Inc; 8.2.1. Overview; 8.2.2. Product List; 8.3. Google Llc; 8.3.1. Overview; 8.3.2. Product List; 8.3.3. Key Strengths; 8.3.4. Key Challenges; 8.4. Ibm Corporation; 8.4.1. Overview; 8.4.2. Product List; 8.4.3. Key Strengths; 8.4.4. Key Challenges; 8.5. Intel Corporation; 8.5.1. Overview; 8.5.2. Product List; 8.5.3. Key Strengths; 8.5.4. Key Challenges; 8.6. Koninklijke Philips Nv; 8.6.1. Company Overview; 8.6.2. Products; 8.6.3. Key Strengths; 8.6.4. Key Challenges; 8.7. Medtronic Plc; 8.7.1. Company Overview; 8.7.2. Product List; 8.7.3. Key Strengths; 8.7.4. Key Challenges; 8.8. Microsoft Corporation; 8.8.1. Company Overview; 8.8.2. Product List; 8.8.3. Key Strengths; 8.8.4. Key Challenges; 8.9. Nvidia Corporation; 8.9.1. Overview; 8.9.2. Product List; 8.9.3. Key Strengths; 8.9.4. Key Challenges; 8.10. Oncora Medical; 8.10.1. Overview; 8.10.2. Product List; 8.11. Recursion Pharmaceuticals Inc; 8.11.1. Overview; 8.11.2. Products; 8.12. Stryker Corporation; 8.12.1. Overview; 8.12.2. Product List; 8.12.3. Key Strengths; 8.12.4. Key Challenges; 8.13. Siemens Healthineers Ag; 8.13.1. Overview; 8.13.2. Product List; 8.13.3. Key Strengths; 8.13.4. Key Challenges
9. Research Methodology & Scope: 9.1. Research Scope & Deliverables; 9.1.1. Objectives Of Study; 9.1.2. Scope Of Study; 9.2. Sources Of Data; 9.2.1. Primary Data Sources; 9.2.2. Secondary Data Sources; 9.3. Research Methodology; 9.3.1. Evaluation Of Proposed Market; 9.3.2. Identification Of Data Sources; 9.3.3. Assessment Of Market Determinants; 9.3.4. Data Collection; 9.3.5. Data Validation & Analysis
List Of Tables: Table 1: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Country Outlook, Historical Years, 2020-2023 (In $ Million); Table 2: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Country Outlook, Forecast Years, 2024-2032 (In $ Million); Table 3: List Of Acquisitions; Table 4: List Of Product Launches; Table 5: List Of Collaborations; Table 6: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Solution, 2024-2032 (In $ Million); Table 7: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Technology, 2024-2032 (In $ Million); Table 8: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Type, 2024-2032 (In $ Million); Table 9: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Industry Vertical, 2024-2032 (In $ Million); Table 10: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Country Outlook, 2024-2032 (In $ Million)
List Of Figures: Figure 1: Porter’s Five Forces Analysis; Figure 2: Market Maturity Analysis; Figure 3: Value Chain Analysis; Figure 4: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Solution, 2023 & 2032 (In %); Figure 5: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Software, 2024-2032 (In $ Million); Figure 6: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Services, 2024-2032 (In $ Million); Figure 7: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Hardware, 2024-2032 (In $ Million); Figure 8: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Technology, 2023 & 2032 (In %); Figure 9: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Natural Language Processing, 2024-2032 (In $ Million); Figure 10: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Querying Method, 2024-2032 (In $ Million); Figure 11: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Context Aware Processing, 2024-2032 (In $ Million); Figure 12: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Deep Learning, 2024-2032 (In $ Million); Figure 13: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Type, 2023 & 2032 (In %); Figure 14: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Robot-assisted Surgery, 2024-2032 (In $ Million); Figure 15: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Virtual Nursing Assistant, 2024-2032 (In $ Million); Figure 16: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Administrative Workflow Assistance, 2024-2032 (In $ Million); Figure 17: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Fraud Detection, 2024-2032 (In $ Million); Figure 18: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Dosage Error Reduction, 2024-2032 (In $ Million); Figure 19: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Clinical Trial Participant Identifier, 2024-2032 (In $ Million); Figure 20: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Preliminary Diagnosis, 2024-2032 (In $ Million); Figure 21: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Other Types, 2024-2032 (In $ Million); Figure 22: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Industry Vertical, 2023 & 2032 (In %); Figure 23: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Healthcare Providers, 2024-2032 (In $ Million); Figure 24: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Pharmaceutical And Biotechnology Companies, 2024-2032 (In $ Million); Figure 25: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Payers, 2024-2032 (In $ Million); Figure 26: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Acos And Mcos, 2024-2032 (In $ Million); Figure 27: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Patients, 2024-2032 (In $ Million); Figure 28: Asia-pacific Artificial Intelligence (Ai) In Healthcare Market, By Country Outlook, 2023 & 2032 (In %); Figure 29: China Artificial Intelligence (Ai) In Healthcare Market 2024-2032 (In $ Million); Figure 30: Japan Artificial Intelligence (Ai) In Healthcare Market 2024-2032 (In $ Million); Figure 31: India Artificial Intelligence (Ai) In Healthcare Market 2024-2032 (In $ Million); Figure 32: South Korea Artificial Intelligence (Ai) In Healthcare Market 2024-2032 (In $ Million); Figure 33: Australia & New Zealand Artificial Intelligence (Ai) In Healthcare Market 2024-2032 (In $ Million); Figure 34: Asean Countries Artificial Intelligence (Ai) In Healthcare Market 2024-2032 (In $ Million); Figure 35: Rest Of Asia-pacific Artificial Intelligence (Ai) In Healthcare Market 2024-2032 (In $ Million)